Biondo Investment Advisors, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 172 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
Biondo Investment Advisors, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$238,000
-0.8%
3,975
-0.6%
0.05%
-11.5%
Q3 2020$240,000
-8.4%
4,000
-20.0%
0.05%
-21.2%
Q2 2020$262,000
-96.3%
5,000
-96.7%
0.07%
-96.3%
Q4 2017$6,993,000
+19.4%
153,185
-1.8%
1.77%
+9.7%
Q3 2017$5,857,000
-22.4%
155,973
-1.4%
1.61%
-26.2%
Q2 2017$7,546,000
+35.9%
158,203
-3.9%
2.18%
+10.0%
Q1 2017$5,553,000
+20.7%
164,622
+15.5%
1.98%
+30.4%
Q4 2016$4,602,000
-17.5%
142,473
-12.6%
1.52%
-19.4%
Q3 2016$5,580,000
+0.4%
163,073
-1.1%
1.89%
-4.8%
Q2 2016$5,560,000
-41.8%
164,827
-8.7%
1.98%
-45.3%
Q1 2016$9,561,000
-51.0%
180,459
-29.0%
3.62%
-44.0%
Q4 2015$19,520,000
+85.4%
254,204
-0.8%
6.48%
+84.9%
Q3 2015$10,530,000
-44.7%
256,209
-4.8%
3.50%
-38.7%
Q2 2015$19,028,000
-23.2%
269,061
-3.5%
5.71%
-22.3%
Q1 2015$24,785,000
-0.9%
278,952
-1.1%
7.35%
-2.2%
Q4 2014$25,000,000
-7.8%
281,977
+0.8%
7.52%
-9.7%
Q3 2014$27,110,000
+4.4%
279,717
-1.1%
8.33%
+1.7%
Q2 2014$25,976,000
+37.5%
282,773
+4.8%
8.19%
+30.9%
Q1 2014$18,886,000
+22.4%
269,836
+0.6%
6.26%
+18.8%
Q4 2013$15,427,000
+21.8%
268,339
+1.9%
5.27%
+9.6%
Q3 2013$12,665,000
+146.1%
263,440
+48.4%
4.81%
+115.3%
Q2 2013$5,147,000177,4902.23%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders